These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2166636)

  • 1. Scintigraphic assessment of an ophthalmic gelling vehicle in man and rabbit.
    Greaves JL; Wilson CG; Rozier A; Grove J; Plazonnet B
    Curr Eye Res; 1990 May; 9(5):415-20. PubMed ID: 2166636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gamma scintigraphic comparison of eyedrops containing pilocarpine in healthy volunteers.
    Meseguer G; Buri P; Plazonnet B; Rozier A; Gurny R
    J Ocul Pharmacol Ther; 1996; 12(4):481-8. PubMed ID: 8951684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the precorneal residence of an artificial tear preparation in patients with keratoconjunctivitis sicca and normal volunteer subjects using gamma scintigraphy.
    Greaves JL; Wilson CG; Galloway NR; Birmingham AT; Olejnik O
    Acta Ophthalmol (Copenh); 1991 Aug; 69(4):432-6. PubMed ID: 1750310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo eye surface residence determination by high-resolution scintigraphy of a novel ion-sensitive hydrogel based on gellan gum and kappa-carrageenan.
    Fernández-Ferreiro A; Silva-Rodríguez J; Otero-Espinar FJ; González-Barcia M; Lamas MJ; Ruibal A; Luaces-Rodríguez A; Vieites-Prado A; Lema I; Herranz M; Gómez-Lado N; Blanco-Mendez J; Gil-Martínez M; Pardo M; Moscoso A; Cortes J; Sánchez-Martínez M; Pardo-Montero J; Aguiar P
    Eur J Pharm Biopharm; 2017 May; 114():317-323. PubMed ID: 28189624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the precorneal residence of an ophthalmic ointment in healthy subjects.
    Greaves JL; Wilson CG; Birmingham AT
    Br J Clin Pharmacol; 1993 Feb; 35(2):188-92. PubMed ID: 8443038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel in situ gelling ophthalmic drug delivery system based on gellan gum and hydroxyethylcellulose: Innovative rheological characterization, in vitro and in vivo evidence of a sustained precorneal retention time.
    Destruel PL; Zeng N; Seguin J; Douat S; Rosa F; Brignole-Baudouin F; Dufaÿ S; Dufaÿ-Wojcicki A; Maury M; Mignet N; Boudy V
    Int J Pharm; 2020 Jan; 574():118734. PubMed ID: 31705970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A gamma scintigraphic evaluation of the precorneal residence of liposomal formulations in the rabbit.
    Fitzgerald P; Hadgraft J; Wilson CG
    J Pharm Pharmacol; 1987 Jun; 39(6):487-90. PubMed ID: 2886611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precorneal residence time in humans of sodium hyaluronate as measured by gamma scintigraphy.
    Gurny R; Ryser JE; Tabatabay C; Martenet M; Edman P; Camber O
    Graefes Arch Clin Exp Ophthalmol; 1990; 228(6):510-2. PubMed ID: 2176168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precorneal drainage of polyvinyl alcohol solutions in the rabbit assessed by gamma scintigraphy.
    Wilson CG; Olejnik O; Hardy JG
    J Pharm Pharmacol; 1983 Jul; 35(7):451-4. PubMed ID: 6136587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scintigraphic studies on the corneal residence of a New Ophthalmic Delivery System (NODS): rate of clearance of a soluble marker in relation to duration of pharmacological action of pilocarpine.
    Greaves JL; Wilson CG; Birmingham AT; Richardson MC; Bentley PH
    Br J Clin Pharmacol; 1992 Jun; 33(6):603-9. PubMed ID: 1389932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of ion-activated in situ gelling systems for ocular drug delivery. Part 2: Precorneal retention and in vivo pharmacodynamic study.
    Rupenthal ID; Green CR; Alany RG
    Int J Pharm; 2011 Jun; 411(1-2):78-85. PubMed ID: 21453763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levofloxacin Hemihydrate In Situ Gelling Ophthalmic Solution: Formulation Optimization and In Vitro and In Vivo Evaluation.
    Bhalerao H; Koteshwara KB; Chandran S
    AAPS PharmSciTech; 2019 Aug; 20(7):272. PubMed ID: 31372767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In situ gelling gelrite/alginate formulations as vehicles for ophthalmic drug delivery.
    Liu Y; Liu J; Zhang X; Zhang R; Huang Y; Wu C
    AAPS PharmSciTech; 2010 Jun; 11(2):610-20. PubMed ID: 20354916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo evaluation of the Gelrite gellan gum-based ocular delivery system for indomethacin.
    Balasubramaniam J; Kant S; Pandit JK
    Acta Pharm; 2003 Dec; 53(4):251-61. PubMed ID: 14769232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical use of chitosan in ophthalmology: tolerance assessment and evaluation of precorneal retention.
    Felt O; Furrer P; Mayer JM; Plazonnet B; Buri P; Gurny R
    Int J Pharm; 1999 Apr; 180(2):185-93. PubMed ID: 10370189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular contact time of a carbomer gel (GelTears) in humans.
    Wilson CG; Zhu YP; Frier M; Rao LS; Gilchrist P; Perkins AC
    Br J Ophthalmol; 1998 Oct; 82(10):1131-4. PubMed ID: 9924298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-Carnosine: multifunctional dipeptide buffer for sustained-duration topical ophthalmic formulations.
    Singh SR; Carreiro ST; Chu J; Prasanna G; Niesman MR; Collette Iii WW; Younis HS; Sartnurak S; Gukasyan HJ
    J Pharm Pharmacol; 2009 Jun; 61(6):733-42. PubMed ID: 19505363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved corneal bioavailability of ofloxacin: biodegradable microsphere-loaded ion-activated in situ gel delivery system.
    Sayed EG; Hussein AK; Khaled KA; Ahmed OA
    Drug Des Devel Ther; 2015; 9():1427-35. PubMed ID: 25792803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of ophthalmic formulations on sodium cromoglycate disposition in the albino rabbit eye.
    Shrewsbury RP; Swarbrick J; Newton KS; Riggs LC
    J Pharm Pharmacol; 1985 Sep; 37(9):614-7. PubMed ID: 2867180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ion-activated in situ gelling systems for sustained ophthalmic delivery of ciprofloxacin hydrochloride.
    Balasubramaniam J; Pandit JK
    Drug Deliv; 2003; 10(3):185-91. PubMed ID: 12944139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.